Entries |
Document | Title | Date |
20080207755 | Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders - This invention relates to a method of treating certain disorders by administering a compound of the formula 1 | 08-28-2008 |
20080214666 | Products and Methods Related to Mono-Methyl Branched-Chain Fatty Acids - Disclosed are genes and proteins related to the biosynthesis and function of mono-methyl branched-chain fatty acids (mmBCFA) in eukaryotes, as well as the functions of mmBCFA in eukaryotic organisms. Also disclosed are methods to regulate the biosynthesis and function of mmBCFA in an organism, methods to use the valuable targets associated with mmBCFA biosynthesis and function as therapeutic agents and to screen for pharmaceuticals and nutraceuticals, or to investigate or screen for regulators of metabolism, growth, development, and reproduction in eukaryotes. The present invention also includes highly specific and useful animal models for mmBCFA biosynthesis and function that can be used to explore pharmaceutical applications of the mmBCFA-involved biological processes. | 09-04-2008 |
20080214667 | Elongase Gene and Uses Thereof - The subject invention relates to the identification of a gene involved in the elongation of polyunsaturated fatty acids containing unsaturation at the carbon 9 position (i.e., “Δ9-elongase”) and to uses thereof. In particular, Δ9-elongase may be utilized, for example, in the conversion of linoleic acid (LA, 18:2n-6) to eicosadienoic acid (EDA, 20:2n-6). The production of dihomo-γ-linolenic acid (DGLA, 20:3n-6) from eicosadienoic acid (EDA, 20:2n-6), and arachidonic acid (AA, 20:4n-6) from dihomo-γ-linolenic acid (DGLA, 20:3n-6) is then catalyzed by Δ8-desaturase and Δ5-desaturase, respectively. AA or polyunsaturated fatty acids produced therefrom may be added to pharmaceutical compositions, nutritional compositions, animal feeds, as well as other products such as cosmetics. | 09-04-2008 |
20080234375 | Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product - The invention relates to a process for decreasing the amount of environmental pollutants in a mixture comprising a fat or an oil, being edible or for use in cosmetics, the fat or oil containing the environmental pollutants, which process comprises the steps of adding a volatile working fluid to the mixture, where the volatile working fluid comprises at least one of a fatty acid ester, a fatty acid amid, a free fatty acid and a hydrocarbon, and subjecting the mixture with the added volatile working fluid to at least one stripping processing step, in which an amount of environmental pollutant present in the fat or oil, being edible or for use in cosmetics, is separated from the mixture together with the volatile working fluid. The present invention also relates to a volatile environmental pollutants decreasing working fluid, for use in decreasing an amount of environmental pollutants present in a fat or oil, being edible or for use in cosmetics. In addition, the present invention relates to a health supplement, a pharmaceutical and an animal feed product prepared according to the process mentioned above. | 09-25-2008 |
20080287540 | LIP CARE COMPOSITIONS - A lip care composition is provided which includes at least 40% petrolatum, at least 5% glycerin, and 1 to 20% of a C | 11-20-2008 |
20080306153 | Lipids and lipid assemblies comprising transfection enhancer elements - Lipid assemblies, such as liposomes, comprising transfection enhancer elements (TEE's), which are complexed with the lipid assemblies by means of ionic interactions, or lipids incorporating such TEE's are disclosed for enhancing the fusogenicity of the lipid assemblies. The TEE's have the formula: | 12-11-2008 |
20080319070 | Sanitizing and Cleaning Composition and its Use for Sanitizing and/or Cleaning Hard Surfaces - The present invention relates to acidic sanitizing and/or cleaning compositions comprising a specific quaternary antimicrobial system consisting of C1-C4 hydroxyalkyl carboxylic acids, C5-C18 alkyl monocarboxylic acids, unsubstituted or substituted, saturated or unsaturated C4-dicarboxylic acids and additional inorganic or organic acids. The compositions of the present invention can be present in the form of concentrates and in the form of diluted use solutions. They can be used in a process for sanitizing and/or cleaning hard surfaces, preferably in a cleaning-in-place (CIP) and/or sanitize-in-place (SIP) process for cleaning and/or sanitizing plants in the food, dairy, beverage, brewery and soft drink industries. | 12-25-2008 |
20090012164 | PINOLENIC ACID COMPOSITIONS, PRODUCTS MADE THEREOF, AND METHODS OF MAKING PINOLENIC ACID COMPOSITIONS AND PRODUCTS - Compositions of pinolenic acid or derivatives thereof. Method of using TOFA for obtaining pinolenic acid or derivatives thereof. Products, including foods, beverages, personal care, beauty, pharaceutical or other products comprising TOFA derived pinolenic acid or derivatives thereof. | 01-08-2009 |
20090018195 | MICROFLUIDIC CHEMOSTAT - A chemostat is described that includes a growth chamber having a plurality of compartments. Each of the compartments may be fluidly isolated from the rest of the growth chamber by one or more actuatable valves. The chemostat may also include a nutrient supply-line to supply growth medium to the growth chamber, and an output port to remove fluids from the growth chamber. Also, a method of preventing biofilm formation in a growth chamber of a chemostat is described. The method may include the steps of adding a lysis agent to a isolated portion of the growth chamber, and reuniting the isolated portion with the rest of the growth chamber. | 01-15-2009 |
20090030078 | THERAPEUTIC AGENT FOR PAIN - The present invention relates to an agent for prevention, treatment or inhibition of symptom progression of a pain and/or for control of an analgesic comprising (2R)-2-propyloctanoic acid, a salt thereof or a prodrug thereof, in which an amount per dose is from 1 mg to 5000 mg (preferably from 10 mg to 5000 mg). By administering (2R)-2-propyloctanoic acid, a salt thereof or a prodrug thereof in an amount per dose within the range as described above, a pain, in particular, a neurogenic pain associated with a disease such as cancer pain, postherpetic pain, diabetic pain, HIV-associated neurogenic pain, calculus-induced pain, neuralgia, orofacial pain or hyperalgesia can be remarkably relieved. Moreover, undesirable effects on the living body relating to the use of an analgesic can be relieved. | 01-29-2009 |
20090036529 | THERAPEUTIC AGENT FOR FUNCTIONAL BRAIN DISEASE - Provision of an agent for preventing or treating a functional brain disease and/or inhibiting symptom development of the same. | 02-05-2009 |
20090048338 | BIOLOGICALLY ACTIVE OILS - A process for the production of fats or oils and their extracts containing biologically active chemical compounds from a lipid substrate, the process comprising: a) inoculation of a lipid substrate with fungally derived lipolytic enzymes; b) incubating the inoculated substrate for a period of between about 7-120 days at a temperature of between about 435° C., at a humidity of between about 75-100%, and c) processing said substrate mixture to obtain a biologically active fat or oil. | 02-19-2009 |
20090062390 | IN-SHOWER LOTION COMPOSITIONS COMPRISING UP TO 10% FREE FATTY ACIDS WHEREIN RATIO OF UNSATURATED TO SATURATED FATTY ACIDS IS AT LEAST 1:1 - This invention relates to rinse-off skin conditioning compositions comprising relatively low amounts of oil/emollient and relatively low amounts of aqueous phase stabilizer/structurant. Use of unsaturated fatty acid (or at least minimum amount of unsaturated fatty acid as percentage of total fatty acid) has been found to result in unexpectedly high hydration. In a second embodiment, use of branched fatty acid (at minimum amount branched as percentage of total) also results in superior hydration. Also mixtures of unsaturated and branched fatty acids can be used. | 03-05-2009 |
20090076149 | Production method of oil or fat containing polyunsaturated fatty acid-containing triglyceride - The present invention relates to a production method of an oil containing triglyceride in which medium chain fatty acids are bound to the 1- and 3-positions of the triglyceride and polyunsaturated fatty acid is bound to the 2 position by allowing lipase, which specifically acts on ester bonds at the 1- and 3-positions that has been immobilized on a porous ion exchange resin support having a pore size of about 100 Angstroms or more, to act on a mixture of medium-chain fatty acids and raw material oil containing at least one polyunsaturated fatty acid selected from the group consisting of ω6 series polyunsaturated fatty acid having 18 or more carbon atoms and 3 or more double bonds and ω9 series polyunsaturated fatty acid having 18 or more carbon atoms and 2 or more double bonds, but not containing ω3 series polyunsaturated fatty acid, oils and fats or triglycerides obtained by that method, and the use of the oils and fats or triglycerides in a food, beverage or pharmaceutical composition. | 03-19-2009 |
20090105340 | COMPOSITION AND/OR METHOD FOR PREVENTING RECURRENCE OF STROKE - By using a composition for preventing onset and/or recurrence of stroke which contains ethyl icosapentate as its effective component, onset and/or recurrence of stroke is prevented, or in particular, the onset and/or recurrence of stroke in a hyperlipidemia patient who has been treated with HMG-CoA RI, or in particular the recurrence of stroke in a patient who is beyond six months after the onset of stroke, is prevented. | 04-23-2009 |
20090111876 | EXTRACTS FROM CHLORELLA - This invention relates to an extract of Chlorella sorokiniana, which contains myristic acid, palmitic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, and stearic acid. Also related is use of this extract to treat diabetes, obesity, and dyslipidaemia. | 04-30-2009 |
20090118371 | Delta 6 Desaturase From Thraustochytrid and its Uses Thereof - The present invention is directed to an isolated delta-6 desaturase gene from Schizochytrium. It is further directed to the cloning of delta-6 desaturase derived from Schizochytrium in Yeast. The nucleic acid sequence and the amino acid sequences of the delta-6 desaturase are disclosed. Further disclosed are the constructs, vector comprising the gene encoding the enzyme delta-6 desaturase in functional combination with the heterologous regulatory sequences. The novel delta-6 desaturase can be used in a metabolic pathway to convert linoleic acid to gamma linolenic acid (omega-6 pathway). The invention provides the identification, isolation of these novel nucleic acids from Schizochytrium that encode the above-mentioned proteins. The invention specifically exemplifies recombinant yeast cells harboring the vector comprising the delta-6 desaturase gene and by the virtue of the enzyme produced shall be able to produce gamnia-linolenic acid. | 05-07-2009 |
20090124693 | Cosmetic Compositions Comprising Hydroxyfatty Acids - The present invention is concerned with novel cosmetic or pharmaceutical compositions. More particularly, the invention is concerned with novel cosmetic or pharmaceutical compositions for treating or preventing any symptoms caused by negative developments of the physiological homeostasis of healthy skin, as well as for the promotion of hair growth and protection from hair loss. | 05-14-2009 |
20090131522 | Skin Cell Activator Extracted From Liver Of Fish Or Shellfish And Hair Growth Agent Using The Same - Disclosed are a skin cell activator extracted from a pufferfish liver, and a hair growth agent comprising 10 volume % or more of the skin cell activator. The skin cell activator comprises an organic substance which contains an alcohol- and other organic solvent-soluble fat/oil component extracted from a pufferfish liver, or a high-polar organic substance which has the fat/oil component and a hydrophilic reactive group selected from a group including a carboxyl group and a hydroxyl group and bound to the fat/oil component. The present invention makes it possible to effectively utilize an internal organ of a fish or shellfish which has conventionally been precluded from utilization. In particular, based on clarification of the hair growth-promoting function of the pufferfish's internal organ, the present invention can provide a novel hair growth agent having a direct hair-growing effect by utilizing the function. | 05-21-2009 |
20090131523 | Lipid compositions for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carinogenesis - Lipid compositions are provided for the treatment and prevention of proliferative diseases and for the reduction of incidences of mutagenesis and carcinogenesis. | 05-21-2009 |
20090149537 | Use of Bile Acid or Bile Salt Fatty Acid Conjugates - The present invention relates to the use of a bile acid or bile salt fatty acid conjugate of general formula II | 06-11-2009 |
20090203783 | THERAPEUTIC AGENT FOR ACUTE CEREBRAL INFARCT - An agent for treating acute cerebral infarction, comprising (2R)-2-propyloctanoic acid or a salt thereof, which is used for administration after a lapse of time of from about 5 hours to about 72 hours from the onset of the disease is useful for treating acute cerebral infarction, since it safely improves acute cerebral infarction or accompanying symptoms in the patient of acute cerebral infarction, specifically in the patient of acute cerebral infarction defined as a score of 7 to 22 on NIH Stroke Scale. | 08-13-2009 |
20090215894 | INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF - Inhibitors of the phosphatase activity of soluble epoxide hydrolase (sEH) are provided and are useful for in the treatment of diseases. These Inhibitors are based on derivatives of various epoxide hydrolase substrates that mimic the enzyme substrate so that there Is stable Interaction with the enzyme catalytic site. These inhibitors are potentially useful for the treatment of hypertension, vascular inflammation, renal inflammation, and lung disease. | 08-27-2009 |
20090270502 | Method for Lowering Risk of Cardiovascular Diseases - The present invention relates to a method for lowering risk of cardiovascular diseases in human, particularly for lowering low density lipoprotein cholesterol (LDL-C) concentration and oxidative stress level while maintaining sufficient high density lipoprotein cholesterol (HDL-C) concentration in human, and to a dietary formulation and a fat or fat blend suitable for human consumption for resulting in the same. The method is by way of controlling daily dietary fat and antioxidants consumption so that: daily dietary fat accounts for 20-40% of the total daily dietary energy intake; 10-20% wt of the fatty acids in daily dietary fat are saturated fatty acids (SFAs); 20-35% wt of the fatty acids in daily dietary fat are polyunsaturated fatty acids (PUFAs); 45-70% wt of the fatty acids in daily dietary fat are monounsaturated fatty acids (MUFAs); and the ratio of antioxidants to polyunsaturated fatty acids (PUFAs) in daily dietary fat is ranging from about 15-70 ppm antioxidants/% wt PUFAs. | 10-29-2009 |
20090275657 | Fatty acid antimicrobial - The novel antimicrobial composition is disclosed including from about 60 to 95% of a lipophilic polar solvent such as propylene glycol, ethylene glycol, or isopropanol and from about 0.5 to 5% of a mixture of C | 11-05-2009 |
20100016430 | MODIFIED COCONUT OILS WITH BROAD ANTIMICROBIAL SPECTRUM - The present invention discloses antimicrobial compositions of modified coconut oil and palm kernel oil derived from catalytic activity of 1,3 positional specific lipases. Said modified oil compositions comprises of free fatty acids (>9.4%), monoglycerides (>1.3%), diglycerides (>22.8%) and triglycerides (>25%) which inhibits the growth of gram positive bacteria i.e. | 01-21-2010 |
20100016431 | GENES ENCODING A NOVEL TYPE OF LYSOPHOPHATIDYLCHOLINE ACYLTRANSFERASES AND THEIR USE TO INCREASE TRIACYLGLYCEROL PRODUCTION AND/OR MODIFY FATTY ACID COMPOSITION - Described nucleic acid molecules (and corresponding peptides) encode lyso-phosphatidylcholine (LPC) acyltransferases. Over-expression of the LPC acyltransferases in a cell may lead to enhanced production of PUFA, or other unusual fatty acids, and/or to increased oil content in the cell. | 01-21-2010 |
20100041754 | Novel natural oil gels and their application - The invention is an article of manufacture, comprising a blend of: (A) from 1 to 50 weight percent of at least one block copolymer, wherein the block copolymer has at least one polystyrene block and at least one unsaturated rubber segment; and (B) from 99 to 50 weight percent of a natural oil. The natural oil of this invention is of natural animal, plant or vegetable oils or mixtures thereof, and the block copolymers have a polystyrene block and a rubber block where the rubber blocks are unsaturated rubbers such as polyisoprene, polybutadiene, or mixtures thereof. The block copolymers useful for the present invention are triblock polymers, radial (star) polymers, multiblock polymers, diblock polymers, or mixtures thereof. | 02-18-2010 |
20100087531 | DIHYDRO-TRITERPENES IN THE TREATMENT OF VIRAL INFECTIONS, CARDIOVASCULAR DISEASE, INFLAMMATION, HYPERSENSITIVITY OR PAIN - The present invention relates to compositions comprising the triterpenes, dihydrobutyrospermol, dihydrolupeol and/or dihydroparkeol, the composition being applicable as a pharmaceutical, a dietary supplement or as a cosmetic. Further, the invention relates to the use of such compositions for the preparation of a medicament, a dietary supplement or a cosmetic for immunomodulating in a mammal such as suppression of viral infections, cardiovascular diseases, cancer, hypersensitivity and/or inflammatory reactions. The triterpenes may be in form of the free alcohol or derivatised, preferably with cinnamic acid, acetic acid or fatty acids. Furthermore, the triterpenes may be an extract obtainable from a natural source or synthetically made. | 04-08-2010 |
20100099764 | PRODUCTION OF ARACHIDONIC ACID IN OILSEED PLANTS - Oilseed plants which have been transformed to produce arachidonic acid, recombinant constructs used in such transformations, methods for producing arachidonic acid in a plant are described and uses of oils and seeds obtained from such transformed plants in a variety of food and feed applications are described. | 04-22-2010 |
20100137437 | Composition for Inactivating an Enveloped Virus - The present invention relates generally to the field of prevention of diseases caused by enveloped viruses. More particularly, this invention concerns a composition for inactivating an enveloped virus comprising at least one non phospholipid Lipid Vesicle (nPLV) able to interact with said enveloped virus and an agent that enhances the lipid exchange between said nPLV and the membrane of said enveloped virus. | 06-03-2010 |
20100204326 | NOVEL AGENTS FOR TREATMENT OF AILMENTS AND DYSFUNCTIONS - The present invention is related to the use of novel agents effective for differential killing of abnormal cells such as cancer cells without damaging or being toxic to normal cells. Further these agents may be used for treating a host of ailments including various types of cancers, skin diseases, prevention and reversal of ageing process, prevention of inflammatory reactions, cure of bacterial infections, cure of fungal infections, etc. The agents are prepared by air oxidation of natural oils optionally in the presence of a catalyst wherein the isolated agents have Iodine value 40-60% of the starting oil, Saponification value 20-60 higher than that of the starting oil, Peroxide value 2-3 times that of the starting oil. These agents on saponification and acidification yield free fatty acids and ether linked fatty acid dimmer wherein the dimmer also acts as an active. | 08-12-2010 |
20100210726 | COMPOSITION FOR PROMOTING KETONE BODY PRODUCTION - Provided is a composition for promoting ketone body production that comprises a water insoluble polymer of a β-hydroxy short-medium chain fatty acid such as homopolymer of β-hydroxybutyric acid or a copolymer of β-hydroxybutyric acid and β-hydroxyvaleric acid. The composition is useful for the treatment or prevention of a disease or condition that can be treated by promoting ketone body production. | 08-19-2010 |
20100227924 | Method For Producing Polyunsaturated Fatty Acids - The invention relates to a method for producing eicosapentanoic acid, docosapentanoic acid and/or docohexanoic acid in transgenic plants. According to said method, the plant is provided with at least one nucleic acid sequence coding for a polypeptide with a Δ6 desaturase activity, at least one nucleic acid sequence coding for a polypeptide with a Δ6 elongase activity, at least one nucleic acid sequence coding for a polypeptide with a Δ5 desaturase activity, and at least one nucleic acid sequence coding for a polypeptide with a Δ5 elongase activity, the nucleic acid sequence coding for a polypeptide with a Δ5 elongase activity being modified in relation to the nucleic acid sequence in the organism from which the sequence originates, such that it is adapted to the codon use in at least one type of plant. For the production of docosahexanoic acid, at least one nucleic acid sequence coding for a polypeptide with a Δ4 desaturase activity is also introduced into the plant. | 09-09-2010 |
20100234460 | Compositions Comprising A C2-C14 Carboxylic Acid And A Surfactant For Treating Hoof Diseases - Germicidal compositions containing at least one carboxylic acid combined with at least one nonionic or anionic surfactant, and methods of using the compositions for treatment or prevention of infectious hoof diseases are disclosed. The germicidal compositions remain active in the presence of manure, which eliminates the need to pre-clean the hooves before use. The compositions have particular utility for treating or preventing papillomatous digital dermatitis, interdigital phlegmon, interdigital dermatitis, laminitis, white line disease, heel erosion and other hoof diseases. | 09-16-2010 |
20100286270 | Compositions For The Treatment Of Hoof Diseases - Germicidal compositions containing one or more N,N-bis(3-aminopropyl) C | 11-11-2010 |
20100317734 | FREE FATTY ACID BLENDS AND USE THEREOF - An antimicrobial composition comprising a blend of two or more natural free fatty acids derivable from milk serum lipid, the free fatty acids being selected from: butyric (C4); caproic (C6); caprylic (C8); capric (C10); lauric (C12); myristic (C14); palmitic (C 16): palmitoleic 5 (C16:1); stearic (C1 8); oleic (C18:1); linoleic (Cl 8:2); linolenic (C18:3); and esterified derivatives thereof, and a milk, protein as an emulsifying agent for the free fatty acids wherein at least 35% of the total lipid content comprises free fatty acids selected from one or more of: butyric, caproic, caprylic, capric and lauric. | 12-16-2010 |
20100331414 | CRYSTAL COMPRISING (2R)-2-PROPYLOCTANOIC ACID AND AMINE - According to the present invention, crystals comprising (2R)-2-propyloctanoic acid and an amine, which can be used as bulk drugs for safely orally administrable solid preparations with keeping the pharmacological effect, are provided. Among these crystals, the crystal with dibenzylamine per se is particularly useful as bulk drug for pharmaceuticals and can be used as an intermediate to produce (2R)-2-propyloctanoic acid having an optical purity of more than 99.5% e.e. which has not been obtained. | 12-30-2010 |
20110009487 | METHOD OF OBTAINING A SOLID COMPONENT RICH IN A PETROSELINIC COMPOUND - A method of obtaining a solid component rich in a petroselinic compound from the seed of a plant of the | 01-13-2011 |
20110046221 | THERAPEUTIC INTERVENTION TO MIMIC THE EFFECT OF CALORIC RESTRICTION - Methods are provided for promoting longevity and decreasing the incidence of aging associated pathologies (e.g., cancer) by the administration of one or more of the following LFFA: linoleic, oleic and palmitic acid. Secondary LFFA derived from this set, as well as their CoA derivatives and synthetic analogs, are effective also in promoting longevity and delaying the onset of age associated disorders. In addition, interventions including LFFA and CoA LLFA formulations are described which protect the organism from acute physical stress, tissue damage and hypoxia (either due to trauma or secondary to surgical procedures. | 02-24-2011 |
20110054026 | ANTIMICROBIAL COMPOSITION AND USE - Antimicrobial compositions are provided comprising a pharmaceutically acceptable organic acid and a pharmaceutically acceptable surfactant. This synergistic combination allows compositions to be formulated at low concentrations that have efficacy in reducing bacterial counts by greater than 3 log within 5 minutes of contact while preserving the organoleptic properties of treated foods, including fresh produce. As shown in FIG. | 03-03-2011 |
20110054027 | PRODUCTION OF BIOFUEL FROM TISSUE CULTURE SOURCES - The present invention provides a method for the production of at least one fatty acid and/or oil from a plant cell suspension culture, the method comprising (i) maintaining a cell suspension culture of oil-producing plant cells under conditions such that the cultured cells synthesise and secrete at least one fatty acid and/or oil into the cell suspension culture medium; and (ii) extracting the thus secreted at least one fatty acid and/or oil from the cell suspension culture medium. | 03-03-2011 |
20110160306 | USE OF ALKANEDICARBOXYLIC ACIDS AND RETINOIDS FOR TREATMENT OF ROSACEA AND OTHER INFLAMMATORY SKIN DISEASES - In order to make available another therapeutic possibility for rosacea the use of at least one α,ω-n-alkanedicarboxylic acid with 7 to 13 carbon atoms or its esters and at least one retinoid for producing a pharmaceutical preparation is proposed. The suggested formulation is also effective in treatment of other inflammatory skin diseases such as psoriasis, atopic dermatitis and common acne. | 06-30-2011 |
20110166227 | BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL - Nutritional fat or oil-based compositions for increasing HDL cholesterol, decreasing total cholesterol (TC), LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma are described. The compositions can advantageously include at least 10% of myristic acid and/or lauric acid in which at least 3% of said fatty acid composition is myristic acid and at least 3% is lauric acid; in some cases at least 1% by weight myristic acid and/or lauric acid is esterified at the sn-2 position in triglyceride molecules. The compositions also include between 5% and 40% by weight linoleic acid, and typically further include at least 10% by weight monounsaturated fatty acids and between 15% and 55% by weight total saturated fatty acids. The sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free. Also described are fat compositions and diets which are adapted to limit increases in blood triglycerides, total cholesterol, LDL, and VLDL, even in the presence of dietary cholesterol. | 07-07-2011 |
20110172307 | ANTIMICROBIAL COMPOSITIONS FOR USE ON FOOD PRODUCTS - The present invention relates to antimicrobial compositions, and specifically antimicrobial compositions that are useful at sanitizing food products. The compositions of the present invention include octanoic acid, an acidulant, a coupling agent, an optional buffer, and water. The compositions of the present invention are composed of GRAS or food additive raw materials. | 07-14-2011 |
20110178176 | USE OF A VIRUCIDAL PREPARATION ON AN AREA OF THE FACE FOR PREVENTION OF TRANSMISSION OR CONTRACTION OF VIRAL ILLNESSES, OR TO SHORTEN THE DURATION OF, OR LESSEN THE SEVERITY OF VIRAL ILLNESSES - A method of reducing or inhibiting the contraction or communication of viral illnesses is proposed. Application of a virucidal preparation containing one or more organic acids (e.g. malic acid) with or without a surfactant (e.g. sodium C | 07-21-2011 |
20110319489 | ENHANCED STABILITY PERACID COMPOSITIONS - The present invention is directed to stabilized peracid compositions. Stabilizing compositions including a metal salt and a chelating agent are added to compositions including peracids. The results stabilized peracid compositions have increased shelf life and storage stability. | 12-29-2011 |
20120029078 | COMPOSITIONS COMPRISING MYRISTIC ACID AND USES THEREOF - The teachings herein are directed to antibacterial and anti-inflammatory pharmaceutical compositions that include myristic acid. Further embodiments herein are directed to methods of administering sufficient amounts of myristic compositions to patients in need thereof in order to prevent or treat inflammation and/or bacterial infection. Myristic acid has been established to outperform other cetylated fatty acids in treating infection and inflammation, such as 1-TDC which includes cetylated myristic acid. The compositions and methods provided herein can further be used with additional anti-inflammatory, antibacterial, and delivery agents. | 02-02-2012 |
20120029079 | PHARMACEUTICAL COMPOSITIONS CONTAINING FLUORINATED OR PERFLUORINATED CARBOXYLIC ACIDS - The molecules of formula (I) are useful in treating diabetes, obesity, hypercholesterolaemia, hyperlipidaemia, cancer, inflammation or other conditions in which modulation of lipis of eicosanoid status or functions may be desirable. Formula (I): Z | 02-02-2012 |
20120035263 | CONDIMENT - The present invention relates to a condiment comprising an emulsion of an aqueous phase and an oil or fat phase, the emulsion comprising a potato protein protease inhibitor isolate. The invention further relates to a method for preparing a condiment according to any of the preceding claims, comprising preparing an aqueous phase comprising the protein protease inhibitor isolate and thereafter dispersing the oil or fat phase in the aqueous phase or dispersing the aqueous phase in the oil or fat phase. | 02-09-2012 |
20120041065 | LAURIC ACID DISTILLATE FOR ANIMAL FEED - Provided are novel methods and formulations for enhancing feed efficiency and reducing mortality in food animals. | 02-16-2012 |
20120046362 | ANTIVIRAL AGENT AND CLEANSING AGENT - It is an object to provide an antiviral agent that can be used for persons having sensitive skin or on the face, inactivates viruses such as a norovirus and an influenza virus, and is excellent in germicidal properties. Further provided is a cleansing agent that does not lead to environmental pollution since the cleansing agent is easily decomposed in the natural environment, scarcely causes eczema and allergic dermatitis since no germicidal agent is added, and has an antiviral performance. The antiviral agent containing a surface-active agent having a C18 unsaturated alkyl group as an active component. It is not always necessary to lather or rinse off with water like cleansing agents such as medicated soaps since the antiviral agent of the present invention at a very low concentration can inactivate the virus. | 02-23-2012 |
20120077877 | MEDIUM CHAIN PEROXYCARBOXYLIC ACID COMPOSITIONS - The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The compositions can include advantageously high levels of the medium chain peroxycarboxylic acid, can be readily made, and/or can exhibit reduced odor. | 03-29-2012 |
20120088830 | SATIETY-INDUCING COMPOSITION - The present invention relates to the field of weight management. The invention particularly relates to a method for inducing satiety. In one of its embodiments, the present invention provides a method for inducing satiety in a human or an animal comprising administering to said human or animal an effective amount of a composition comprising a lipid of which at least part is in a crystal form in the small intestine. | 04-12-2012 |
20120122980 | METHOD FOR MAKING A PEROXYCARBOXYLIC ACID - The present invention relates to apparatus and methods for making a peroxycarboxylic acid. The apparatus includes a reaction catalyst and a guard column for pretreating one or more reagents, which can increase the life, activity, and/or safety of the reaction catalyst. The peroxycarboxylic acid compositions made by the method and apparatus can include one or more peroxycarboxylic acids. | 05-17-2012 |
20120129936 | ANTIMICROBIAL COMPOSITIONS FOR USE ON FOOD PRODUCTS - The present invention relates to antimicrobial compositions, and specifically antimicrobial compositions that are useful at sanitizing food products. The compositions of the present invention include octanoic acid, an acidulant, a coupling agent, an optional buffer, and water. The compositions of the present invention are composed of GRAS or food additive raw materials. | 05-24-2012 |
20120136056 | Pesticidal Compositions For Insects And Arthropods - The present invention provides an insect or arthropod pesticidal composition. The composition includes active ingredients having a mixture of fatty acids, each of the fatty acids having a straight carbon chain from 6 to 12 carbon atoms long. The fatty acid mixture includes a first fatty acid molecule having a straight carbon chain from 6 to 8 carbon atoms long, and a carboxylic acid group. The fatty acid mixture also includes a second fatty acid molecule having a straight carbon chain from 8 to 12 carbon atoms long, and a carboxylic acid group. The composition also includes a carrier that promotes adherence or absorption or transport across the surface of insects or arthropods to effect their incapacitation or death. | 05-31-2012 |
20120157528 | LEAVE-ON NONSOLID SKIN CONDITIONING COMPOSITIONS CONTAINING 12-HYDROXYSTEARIC ACID AND ETHOXYLATED HYDROGENATED CASTOR OIL - Leave-on non-solid skin conditioning compositions comprising 12-hydroxy stearic acid. Compositions contain 12HSA, yet have a relatively low viscosity, so are suitable for spreading on the skin, and are stable on storage and structurally reversible through temperature cycling. | 06-21-2012 |
20120172439 | GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND THEIR USE AS TEXTILE BLEACHING AND ANTIMICROBIAL AGENTS - The present disclosure provides methods for generating percarboxylic acid compositions and/or peroxycarboxylic acid compositions formed external to a point of use in non-equilibrium reactions for use in certain bleaching and antimicrobial applications, in particular laundry applications. The compositions are generated external to a point of use, at alkaline pH levels, viz. greater than about pH 12, and optionally suitable for use with detergents and/or surfactants for synergistic bleaching efficacy. Methods of bleaching and/or disinfecting are further provided. | 07-05-2012 |
20120172440 | IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF - The present disclosure is related to percarboxylic acid compositions formed in situ in non-equilibrium reactions. The peroxycarboxylic acid compositions are formed using ester based starting materials. Methods for using the percarboxylic acid compositions are also disclosed. | 07-05-2012 |
20120172441 | IN SITU GENERATION OF PEROXYCARBOXYLIC ACIDS AT ALKALINE pH, AND METHODS OF USE THEREOF - The present disclosure is related to percarboxylic acid compositions formed in situ in non-equilibrium reactions. The peroxycarboxylic acid compositions are formed using ester based starting materials. Methods for using the percarboxylic acid compositions are also disclosed. | 07-05-2012 |
20120172442 | METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS, COLIC, AND SHORT BOWEL SYNDROME IN AN INFANT, TODDLER, OR CHILD - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 07-05-2012 |
20120172443 | NUTRITIONAL PRODUCTS INCLUDING A NOVEL FAT SYSTEM INCLUDING MONOGLYCERIDES - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 07-05-2012 |
20120214871 | LEAVE-ON NONSOLID OIL-CONTINUOUS SKIN CONDITIONING COMPOSITIONS CONTAINING 12-HYDROXYSTEARIC ACID - Leave-on non-solid oil-continuous skin conditioning compositions comprising 12-hydroxy stearic acid. Compositions contain 12HSA, yet have a relatively low viscosity, so are suitable for spreading on the skin, and are stable on storage and structurally reversible through temperature cycling. | 08-23-2012 |
20120214872 | BILE ACID OR BILE SALT FATTY ACID CONJUGATES - A method for treating a disease or disorder associated with altered glucose metabolism or insulin action in a subject in need thereof. The method includes administering to the subject a BAFAC (bile acid or bile salt fatty acid conjugate) of general formula II: | 08-23-2012 |
20120225943 | DETERGENTS CAPABLE OF CLEANING, BLEACHING, SANITIZING AND/OR DISINFECTING TEXTILES INCLUDING SULFOPEROXYCARBOXYLIC ACIDS - The present invention relates to novel combined laundry detergent, bleach, and antimicrobial composition incorporating novel sulfoperoxycarboxylic acid compounds, and methods for making and using them. The sulfoperoxycarboxylic compounds used in compositions of the invention are storage stable, water soluble and have low to no odor. Compositions of the invention may be in the form of a liquid, a solid, or a gel. The sulfoperoxycarboxylic compounds useful in preparing compositions of the present invention can be formed from non-petroleum based renewable materials. | 09-06-2012 |
20120225944 | TRIACYGLYCEROL-BASED ALTERNATIVE TO PARAFFIN WAX - A triacylglycerol-based wax, which can be used in candle making, is provided. The triacylglycerol-based material is predominantly includes a triacylglycerol stock which has a fatty acid profile has no more than about 25 wt. % fatty acids having less than 18 carbon atoms. In addition, the fatty acid profile of the triacylglycerol typically includes at least about 50 wt. % 18:1 fatty acid and no more than about 25 wt. % 18:0 fatty acid. In another embodiment, the triacylglycerol-based material is characterized in part by an Iodine Value of about 60 to about 75. For applications such as candles, the wax commonly includes a hydrogenated vegetable oil and palmitic acid. Candles formed from triacylglycerol-based material and methods of producing the candles are also provided. | 09-06-2012 |
20120232144 | Methods of and Systems for Producing Diesel Blend Stocks - A method for producing biofuels is provided. A method of making biofuels includes dewatering substantially intact algal cells to make an algal biomass, extracting neutral lipids from the algal biomass, and esterifying the neutral lipids with a catalyst in the presence of an alcohol. The method also includes separating a water soluble fraction comprising glycerin from a water insoluble fraction comprising fuel esters and distilling the fuel esters under vacuum to obtain a C16 or shorter fuel esters fraction, a C16 or longer fuel ester fraction, and a residue comprising carotenoids and omega-3 fatty acids. The method further includes hydrogenating and deoxygenating at least one of (i) the C16 or shorter fuel esters to obtain a jet fuel blend stock and (ii) the C16 or longer fuel esters to obtain a diesel blend stock. | 09-13-2012 |
20120289599 | COUPLERS FOR MEDIUM-CHAIN FATTY ACIDS AND DISINFECTING COMPOSITIONS - A disinfecting shower cleaner composition including a medium-chain fatty acid coupled with a nonionic surfactant providing temperature stable antimicrobial compositions. The invention specifically relates to antimicrobial compositions including fatty acid antimicrobial agents coupled with an ethoxylated amine and methods of using the antimicrobial compositions. | 11-15-2012 |
20120309830 | MIXED FATTY ACID SOAP/FATTY ACID BASED INSECTICIDAL, CLEANING, AND ANTIMICROBIAL COMPOSITIONS - The present disclosure relates to compositions including a fatty acid soap/fatty acid mixture, and methods of use thereof. The compositions include a C5 to C12 fatty acid or mixtures thereof. The compositions show increased activity, e.g., insecticidal, soil removal, antimicrobial activity, at a controlled pH range of about 7.5 to about 9.0. | 12-06-2012 |
20120316239 | METHOD FOR PREPARING PERSONAL CARE COMPOSITION COMPRISING MONOALKYL AMINE DUAL SURFACTANT SYSTEM AND SOLUBLE SALT - Disclosed is a method of preparing a personal care composition wherein the composition comprising a dual cationic surfactant system of a mono-alkyl amine salt and di-alkyl cationic surfactant, high melting point fatty compounds and soluble salts, and wherein the method comprising the following steps: preparing oil phase at a higher temperature; preparing an aqueous phase at a lower temperature; and mixing them in a high shear field with a rotating member. By the addition of a soluble salt, the surfactants, together with high melting point fatty compounds, can effectively transform to emulsions. | 12-13-2012 |
20130012581 | TREATMENT OF HEAD LICE INFESTATIONS - Techniques and apparatus for treating head lice infestations are described. Some embodiments include a nit (louse egg) detection plate that provides a surface against which irregularities of a hair of a person are more apparent to a viewer than without the detection plate. The detection plate may also include a serrated edge that is operable to separate hairs of the person for viewing over the detection plate. Other embodiments provide a method for using the detection plate to detect and remove nits from hairs of a person. The method may include placing a thin layer of hair of a person over the detection plate, detecting nits by viewing the hairs against a backdrop provided by the detection plate, and removing any detected nits. | 01-10-2013 |
20130041029 | METHODS AND LIPID COMPOSITIONS FOR PROMOTING DEVELOPMENT OF GUT FLORA - Disclosed is a method of inducing and promoting development of beneficial gut flora in a subject and/or of reducing the frequency and duration of crying periods in a subject, the method comprises administering to the subject a lipid composition comprising a vegetable-derived fat source, wherein the fat source is a triglyceride fat source comprising triglycerides with 15-55% palmitic acid moieties out of the total fatty acids, and wherein the level of palmitic acid moieties at the sn-2 position of the glycerol backbone is at least 30% of total palmitic acid. The method is particularly intended for children. Specific fat sources, as well as food articles and a commercial package comprising the same are disclosed. | 02-14-2013 |
20130041030 | SULFOPEROXYCARBOXYLIC ACIDS, THEIR PREPARATION AND METHODS OF USE AS BLEACHING AND ANTIMICROBIAL AGENTS (PSOA) - The present invention relates to novel sulfoperoxycarboxylic acid compounds, and methods for making and using them. The sulfoperoxycarboxylic compounds of the invention are storage stable, water soluble and have low to no odor. Further, the compounds of the present invention can be formed from non-petroleum based renewable materials. The compounds of the present invention can be used as antimicrobials, and bleaching agents. The compounds of the present invention are also suitable for use as coupling agents. | 02-14-2013 |
20130123359 | FIVE AND FIFTEEN CARBON FATTY ACIDS FOR TREATING METABOLIC DISORDERS AND AS NUTRITIONAL SUPPLEMENTS - According to the present invention, acquired metabolic derangements or fatty acid disorders in humans that are manifested by a deficiency in at least one enzyme involved in fatty acid metabolism are treated with a five carbon or a fifteen carbon fatty acid source. Rapid nutritional supplementation can also be provided to a mammalian cell by providing either a five carbon or fifteen carbon fatty acid source. Dietary formulations suitable for human consumption comprising either a five carbon fatty acid, a fifteen carbon fatty acid or triglycerides thereof is also disclosed. | 05-16-2013 |
20130123360 | METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION - The present invention relates to a method of identifying a compound useful for the treating, reducing or preventing pathogenic infection caused by a microorganism and to the use of the PqsD protein or a functional fragment or variant thereof for the identification of a compound having said effect. | 05-16-2013 |
20130172417 | MEDIUM CHAIN PEROXYCARBOXYLIC ACID COMPOSITIONS - The present invention relates to compositions including medium chain peroxycarboxylic acid, methods for making these compositions, and methods for reducing the population of a microorganism. The compositions can include advantageously high levels of the medium chain peroxycarboxylic acid, can be readily made, and/or can exhibit reduced odor. | 07-04-2013 |
20130197085 | AGENT AND METHOD FOR STABILIZING MEMBRANE PROTEIN - [Problems to be Solved] It is an object of the present invention to provide an agent and a method for maintaining and promoting the stability of a membrane protein, and in particular, a transporter (for example, an ABC transporter) on a cell membrane. | 08-01-2013 |
20130253058 | SATIETY-INDUCING COMPOSITION - The present invention relates to the field of weight management. The invention particularly relates to a method for inducing satiety. In one of its embodiments, the present invention provides a method for inducing satiety in a human or an animal comprising administering to said human or animal an effective amount of a composition comprising a lipid of which at least part is in a crystal form in the small intestine. | 09-26-2013 |
20130253059 | MIXED FATTY ACID SOAP/FATTY ACID INSECTICIDAL, CLEANING, AND ANTIMICROBIAL COMPOSITIONS - The present disclosure relates to compositions including a fatty acid soap/fatty acid mixture, and methods of use thereof. The compositions include a C5 to C12 fatty acid or mixtures thereof. The compositions show increased activity, e.g., insecticidal, soil removal, antimicrobial activity, at a controlled pH range of about 7.5 to about 9.0. | 09-26-2013 |
20130274335 | Pet Food Compositions and Methods for Treating Arthritis and Inflammation Associated with Arthritis - The present invention provides food compositions that are effective in treating arthritis or inflammation associated with arthritis in a companion animal, preferably a canine or feline. | 10-17-2013 |
20130281533 | Pet Food Compositions and Methods for Weight Loss and Matinenance - The present invention provides food compositions and methods for companion animals that are effective in preventing or treating obesity. | 10-24-2013 |
20130289117 | HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES - The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents. | 10-31-2013 |
20130303616 | THERAPEUTIC USE OF COMPOUNDS - A compound having the formula (I) R1-COOH wherein R1 is an alkyl or alkenyl group having a C | 11-14-2013 |
20130317105 | SILICONE MODIFIED FATTY ACIDS, METHOD OF PREPARATION AND USAGE THEREOF - The present invention relates to silicone modified fatty carboxylic acid compounds. More specifically, the present invention is derived from low molecular weight, i.e., short chain, silicone modified fatty carboxylic acids, their use and method of making same. The present invention provides for a silicone compound partially derived from a natural product, sapucainha oil, for use in cosmetic formulations. | 11-28-2013 |
20130331448 | COMPOSITIONS COMPRISING 20-CARBON FATTY ACIDS AND METHODS OF MAKING AND USING SAME - The present disclosure provides a process for producing 20-carbon fatty acids from a plant seed oil, the process comprising: a) providing a plant seed oil comprising fatty acids, wherein the fatty acids include 18-carbon fatty acids; and b) elongating the fatty acids by two carbon atoms to produce a composition comprising 20-carbon fatty acids. | 12-12-2013 |
20140148512 | Soap capable of treating seborrheic keratoses, keratosis pilaris, keratoderma, and related conditions and methods of making and using - Embodiments include a soap capable of treating seborrheic keratoses, keratosis pilaris, keratoderma, and/or related conditions, comprising a soap base and additives including pumice and polyethylene. Embodiments further include a method of making and using the soap, comprising providing the soap base and the additives including pumice and polyethylene, mixing the soap base and the additives together, and forming the soap from the soap base and the additives. Embodiments also include a method of using the soap, comprising providing the soap comprising the soap base and additives including pumice and polyethylene, and placing the soap in rubbing contact with the seborrheic keratoses, keratosis pilaris, keratoderma, or related conditions. | 05-29-2014 |
20140163101 | CAPRYLATE VIRAL DEACTIVATION - Described herein are methods for inactivating viruses using caprylate in solutions containing albumin. | 06-12-2014 |
20140249224 | METHODS FOR IMPROVING TOLERANCE, DIGESTION, AND LIPID SOLUBLE NUTRIENT ABSORPTION IN AN INFANT, TODDLER, OR CHILD - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 09-04-2014 |
20140256811 | EFFICIENT STABILIZER IN CONTROLLING SELF ACCELERATED DECOMPOSITION TEMPERATURE OF PEROXYCARBOXYLIC ACID COMPOSITIONS WITH MINERAL ACIDS - Highly acidic, stabilized peroxycarboxylic acid compositions are disclosed as having both improved antimicrobial efficacy in comparison to conventional peroxyoctanoic acid and peroxyacetic acid compositions for sanitizing applications, and improved transport and shipping stability. In particular, low odor and low/no VOC compositions having dual functionality as both acid wash and sanitizing compositions are disclosed. | 09-11-2014 |
20140275255 | ANTIVIRAL COMPOSITIONS AND METHODS FOR INACTIVATING NON-ENVELOPED VIRUSES USING ALKYL 2-HYDROXYCARBOXYLIC ACIDS - The present invention is directed to antiviral compositions that provide efficacy against non-envelope viruses such as noroviruses. The antiviral compositions comprise an alkyl 2-hydroxycarboxylic acid and an effective amount of a sulfonated surfactant. The composition may be used as a topical on human skin, as a hand sanitizer or as a hard surface cleaning composition. | 09-18-2014 |
20140323574 | INFANT FORMULA WITH HIGH SN-2 PALMITATE AND OLIGOFRUCTOSE - An infant formula having a relatively high content of triglycerides having palmitic acid in the sn-2 position. The formula may include oligofructose. The formula may also include at least one omega 6 fatty acid and at least one omega 3 fatty acid. The formula may also have a relatively low protein content and an alpha-lactalbumin content similar to human milk The invention also includes a method for improving the stool consistency, increasing bifidobacteria in the colon, reducing potentially pathogenic bacteria in the colon and reducing calcium soaps in the stool of a formula-fed infant. | 10-30-2014 |
20140357718 | COMPOSITIONS FOR USE IN CONTROLLING INTESTINAL MICROFLORA - The present invention relates to compositions containing organic acids and emulsifiers and their use in controlling intestinal microflora in production animals. In particular, the present invention relates to the use of such compositions for reducing foodborne pathogens. | 12-04-2014 |
20140364502 | LIPOIC ACID DERIVATIVES - Lipoic acid derivatives and pharmaceutical formulations containing lipoic acid derivatives are useful in the treatment and prevention of disease characterized by disease cells that are sensitive to lipoic acid derivatives. | 12-11-2014 |
20140371314 | Deuterated Tetramethyl Dioic Acids, Compositions Comprising Them And Uses Thereof - This invention relates to deuterated tetramethyl dioic acids, compositions comprising them and uses thereof in the treatment of Metabolic Syndrome and any diseases, disorders or symptoms associated therewith. | 12-18-2014 |
20140378544 | CONTINUOUS ON-LINE ADJUSTABLE DISINFECTANT/SANITIZER/BLEACH GENERATOR - Methods and systems for on-site, continuous generation of peracid chemistry, namely peroxycarboxylic acids and peroxycarboxylic acid forming compositions, are disclosed. In particular, an adjustable biocide formulator or generator system is designed for on-site generation of peroxycarboxylic acids and peroxycarboxylic acid forming compositions from sugar esters. Methods of using the in situ generated peroxycarboxylic acids and peroxycarboxylic acid forming compositions are also disclosed. | 12-25-2014 |
20150025145 | ANTIMICROBIAL COMPOSITION CONTAINING LAURIC ACID AND METHODS FOR THEIR PRODUCTION - The present invention relates to the method of producing an antimicrobial composition characterized in that it comprises the steps of: a) splitting a lauric oil treated with activated carbon; and b) recovering a composition comprising 90% or more, by weight of free fatty acids. The invention further relates to antimicrobial compositions obtained by said process, to feed, food or beverage comprising said composition and to their uses. | 01-22-2015 |
20160089407 | USE OF TALL OIL FATTY ACID - The present invention relates to use of a tall oil fatty acid in enhancing rumen fermentation and/or lowering rumen methane production. The invention further relates to use of a feed supplement and a feed composition comprising tall oil fatty acid | 03-31-2016 |
20160120180 | COMPOSITIONS AND METHODS FOR CONTROLLING REPLANT DISEASES OF PERENNIAL CROPS - The present invention relates to compositions and methods for treating a broad set of syndromes collectively known as replant diseases or replant problems without harming the treated plant. The compositions and methods include fatty acids and combinations of fatty acids that are environmentally safe, yet highly effective at treating replant disease and its symptoms. The compositions and methods of the present invention do not result in the creation of toxic waste that requires special disposal. The compositions and methods of the present invention do not require buffer zones where no application can be made. The compositions and methods of the present invention do not require modification of fatty acids that decrease their effective pesticidal activity. The compositions and methods of the present invention do not result in phytotoxicity of growing plants. The compositions and methods of the present invention cause vigorous growth and reversal of symptoms of plants affected with replant disease, including faster development of productive spurs/stems and larger fruit. | 05-05-2016 |
20160120832 | LIPID SCAVENGING IN RAS CANCERS - Methods and compositions for treating Ras-related cancers are provided that involve targeting lipid scavenging. Methods and compositions for identifying and/or characterizing more or less responsive cancers are also provided. | 05-05-2016 |
20160136122 | METHODS FOR TREATING PSORIATIC ARTHRITIS - Methods, agents and compositions thereof for treating psoriatic arthritis (PsA) are encompassed herein. | 05-19-2016 |
20160165908 | COMPOSITIONS AND METHODS FOR LOWERING COUNTS OF PATHOGENIC MICROORGANISMS IN FOOD PRODUCTS | 06-16-2016 |
20160193170 | Use of Heptadecanoic Acid (C17:0) To Detect Risk Of And Treat Hyperferritinemia and Metabolic Syndrome | 07-07-2016 |
20160193172 | Method For Treating Metabolic Syndrome | 07-07-2016 |
20160250171 | USE OF TALL OIL FATTY ACID IN BINDING TOXINS | 09-01-2016 |
20160374337 | ANTIMICROBIAL COMPOSTION CONTAINING LAURIC ACID AND METHOD FOR THEIR PRODUCTION - The present invention relates to the method of producing an antimicrobial composition characterized in that it comprises the steps of: a) splitting an lauric oil treated with activated carbon; and b) recovering a composition comprising 90% or more, by weight of free fatty acids. The invention further relates to antimicrobial compositions obtained by said process, to feed, food or beverage comprising said composition and to their uses. | 12-29-2016 |
20160374973 | SOAP COMPOSITIONS AND METHODS - Natural soap compositions and methods of manufacturing the same having anti-microbial properties for treating and preventing diaper rash and other microbial infections. The soap compositions may contain one or more fatty acids with carbon length ranging from four (C4) to twenty-two (C22) and/or natural fatty acid mixtures of coconut oil, olive oil, and/or tall oil fatty acids which are saponified with lye. The saponification lye may be sodium or potassium hydroxide. In preferred embodiments, the soap compositions contain at least one of sodium or potassium caprate, sodium or potassium caprylate, or mixtures thereof, especially 55:45% caprylate to caprate. The soap compositions are effective at treating or preventing diaper rashes and other microbial infections associated with | 12-29-2016 |
20170231933 | SUPPORTING IMMUNOMODULATORY AGENT | 08-17-2017 |